May 18, 2022
3 min watch
Save
VIDEO: Oral immunotherapy verification process safely limits disruptions in treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Jeramy Tabuzo, BSN, RN, OCN, discussed her study, presented at Oncology Nursing Society Congress 2022, on improving the verification process and administration polices for oral investigational chemotherapy/immunotherapy.
Tabuzo, a clinical trials oncology nurse at Smilow Cancer Hospital, Yale New Haven Health in Connecticut, explained why the new process is beneficial, saying the improved workflow minimizes disruptions in care.
Published by:
Sources/Disclosures
Collapse
Source:
Tabuzo J, et al. Abstract O26: Oral Investigational Chemotherapy/Immunotherapy Verification Process. Presented at: ONS Congress; April 27-May 1, 2022; Anaheim.
Disclosures:
Tabuzo reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.